GSA Capital Partners LLP lifted its stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR – Free Report) by 73.9% during the 3rd quarter, Holdings Channel reports. The fund owned 10,336 shares of the company’s stock after buying an additional 4,393 shares during the quarter. GSA Capital Partners LLP’s holdings in Semler Scientific were worth $243,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of SMLR. CWM LLC raised its stake in Semler Scientific by 486.3% during the second quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after purchasing an additional 744 shares during the period. Newbridge Financial Services Group Inc. acquired a new stake in shares of Semler Scientific during the 2nd quarter worth approximately $34,000. Quest Partners LLC purchased a new stake in shares of Semler Scientific during the 2nd quarter valued at approximately $59,000. Meeder Asset Management Inc. acquired a new position in Semler Scientific in the second quarter valued at approximately $67,000. Finally, US Bancorp DE grew its position in Semler Scientific by 60.8% in the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after acquiring an additional 1,158 shares during the period. Hedge funds and other institutional investors own 49.37% of the company’s stock.
Insider Activity
In other Semler Scientific news, CEO Douglas Murphy-Chutorian sold 10,000 shares of Semler Scientific stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total transaction of $283,500.00. Following the transaction, the chief executive officer now owns 60,220 shares of the company’s stock, valued at $1,707,237. The trade was a 14.24 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 30.20% of the company’s stock.
Semler Scientific Trading Down 4.2 %
Semler Scientific (NASDAQ:SMLR – Get Free Report) last posted its earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The firm had revenue of $13.51 million for the quarter.
About Semler Scientific
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.
Recommended Stories
- Five stocks we like better than Semler Scientific
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- What Are Dividend Champions? How to Invest in the Champions
- MarketBeat Week in Review – 11/18 – 11/22
- Differences Between Momentum Investing and Long Term Investing
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (NASDAQ:SMLR – Free Report).
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.